Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell Lymphoma
Condition: Untreated Mantle Cell Lymphoma Interventions: Drug: zanubrutinib and rituximab; Drug: BEAM pretreatment; Drug: zanubrutinib maintenance Sponsor: The First Affiliated Hospital of Soochow University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials